Description

NSE announces listing of Medistep Healthcare Limited equity shares on EMERGE SME Platform effective August 18, 2025

Summary

NSE announces the listing of Medistep Healthcare Limited equity shares on the EMERGE SME Platform effective August 18, 2025. The company will trade under symbol ‘MEDISTEP’ with 14,209,546 equity shares of Rs. 10/- face value each, issued at Rs. 43/- per share. Trading will initially occur in Trade for Trade Surveillance Segment (TFTS) with settlement type ‘W’ before shifting to normal rolling segment.

Key Points

  • Symbol: MEDISTEP on NSE EMERGE SME Platform
  • Total shares: 14,209,546 equity shares of Rs. 10/- each
  • Issue price: Rs. 43/- per share
  • ISIN: INE0UOY01019
  • Minimum trading lot: 3,000 equity shares
  • Initial trading in Series ‘ST’ (TFTS), later shifting to Series ‘SM’
  • Market maker spread within 10%
  • Pre-open session applicable for IPO category

Regulatory Changes

The security will be available for trading in continuous market as per Exchange Circular No. NSE/CMTR/37202 dated March 14, 2018. Initial trading in Trade for Trade Surveillance Segment follows SEBI circular no. CIR/MRD/DP/01/2012 & CIR/MRD/DP/02/2012 dated January 20, 2012.

Compliance Requirements

  • Members must use designated security codes for trading
  • Trading must be in specified lot sizes of 3,000 shares
  • Market maker maximum permissible spread within 10%
  • Lock-in requirements apply to specific share tranches

Important Dates

  • Listing effective date: August 18, 2025
  • Lock-in periods: Various tranches locked until August 24, 2027 and August 24, 2028
  • Financial year: April 2025 - March 2026

Impact Assessment

Adds new investment opportunity in healthcare sector SME segment. Limited immediate market impact due to SME platform nature and initial TFTS trading restrictions. Provides liquidity avenue for existing shareholders post lock-in periods. Market maker arrangement ensures orderly trading with controlled spreads.

Impact Justification

New SME listing adds trading opportunity but limited broader market impact